IN192748B - - Google Patents

Info

Publication number
IN192748B
IN192748B IN778DE2000A IN192748B IN 192748 B IN192748 B IN 192748B IN 778DE2000 A IN778DE2000 A IN 778DE2000A IN 192748 B IN192748 B IN 192748B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Ashok Rampal
Rajeev Singh Ranhuvanshi
Manoj Kumar
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN778DE2000 priority Critical patent/IN192748B/en
Priority to AU2001284324A priority patent/AU2001284324A1/en
Priority to US09/941,970 priority patent/US20020081332A1/en
Priority to EP01963298A priority patent/EP1315478A2/en
Priority to PCT/IB2001/001564 priority patent/WO2002017885A2/en
Publication of IN192748B publication Critical patent/IN192748B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN778DE2000 2000-08-29 2000-08-29 IN192748B (ru)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN778DE2000 IN192748B (ru) 2000-08-29 2000-08-29
AU2001284324A AU2001284324A1 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof
US09/941,970 US20020081332A1 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof
EP01963298A EP1315478A2 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof
PCT/IB2001/001564 WO2002017885A2 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN778DE2000 IN192748B (ru) 2000-08-29 2000-08-29

Publications (1)

Publication Number Publication Date
IN192748B true IN192748B (ru) 2004-05-15

Family

ID=11097084

Family Applications (1)

Application Number Title Priority Date Filing Date
IN778DE2000 IN192748B (ru) 2000-08-29 2000-08-29

Country Status (5)

Country Link
US (1) US20020081332A1 (ru)
EP (1) EP1315478A2 (ru)
AU (1) AU2001284324A1 (ru)
IN (1) IN192748B (ru)
WO (1) WO2002017885A2 (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
HUP0302466A2 (hu) * 2000-02-29 2003-11-28 Teva Pharmaceutical Industries Ltd. Eljárások clarithromycin, clarithromycin intermedier, gyakorlatilag oximmentes clarithromycin és ezt tartalmazó gyógyszerkészítmény előállítására
MXPA02009587A (es) * 2000-03-28 2003-05-14 Biochemie Gmbh Particulas granuladas con sabor enmascarado.
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
ZA200404023B (en) * 2001-11-21 2005-05-24 E Z Em Inc Formulations for use in medical or diagnostic procedures.
US20070167380A1 (en) * 2002-04-03 2007-07-19 Rahul Dabre Taste masked compositions of erythromycin a and derivatives thereof
BR0308989A (pt) * 2002-04-03 2005-01-04 Ranbaxy Lab Ltd Formulações de claritromicina com biodisponibilidade aperfeiçoada e processo de preparação das mesmas
US7063862B2 (en) * 2003-06-03 2006-06-20 Biokey, Inc. Pharmaceutical composition and method for treating
WO2005004919A2 (en) * 2003-07-02 2005-01-20 Eurand, Inc. Extended release systems for macrolide antibiotics
JP2006528189A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1646367A4 (en) * 2003-07-21 2011-06-15 Nesher Solutions Ltd ORAL DOSAGE FORMS WITH CONTROLLED RELEASE ON GELLAN RUBBER BASE A NEW PLATFORM TECHNOLOGY FOR MAGNETIC RETENTION
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8168228B2 (en) 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20050260263A1 (en) * 2004-05-18 2005-11-24 Panion & Bf Biotech Inc. Sustained release formulation for sparingly soluble main drugs
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2011125075A2 (en) * 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2671571A1 (en) * 2012-06-05 2013-12-11 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-release formulations of clarithromycin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
GB1577196A (en) * 1977-06-03 1980-10-22 Ile De France Compositions containing erythromycin and metoclopramide
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
BR9913696A (pt) * 1998-09-14 2001-10-09 Ranbaxy Lab Ltd Sistema de liberação de drogas, administrado oralmente, proporcionando controle temporal e espacial
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina

Also Published As

Publication number Publication date
AU2001284324A1 (en) 2002-03-13
US20020081332A1 (en) 2002-06-27
WO2002017885A2 (en) 2002-03-07
EP1315478A2 (en) 2003-06-04
WO2002017885A3 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
BE2017C009I2 (ru)
BE2014C019I2 (ru)
BRPI0113420B8 (ru)
JP2001205716A5 (ru)
BRPI0110940B8 (ru)
IN192748B (ru)
BE2014C025I2 (ru)
JP2001061828A5 (ru)
BRPI0000763B8 (ru)
IN192067B (ru)
CN3141017S (ru)
CN3144584S (ru)
AU2000278563A8 (ru)
CL2006000179A1 (ru)
CN3135489S (ru)
CN3135789S (ru)
CN3135921S (ru)
CN3136619S (ru)
CN3136721S (ru)
CN3137256S (ru)
CN3139578S (ru)
CN3139849S (ru)
CN3139997S (ru)
CN3141005S (ru)
AU2000266391A8 (ru)